Search
Descriptor English: Peplomycin
Descriptor Spanish: Peplomicina
Descriptor peplomicina
Entry term(s) pepleomicina
Scope note: Sustancia antineoplásica derivada de la BLEOMICINA.
Descriptor Portuguese: Peplomicina
Descriptor French: Péplomycine
Entry term(s): NK 631
NK-631
NK631
Pepleomycin
Peplomycin Sulfate
Peplomycin Sulfate (1:1)
Sulfate, Peplomycin
Tree number(s): D09.400.420.110.690
D12.644.233.110.690
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D017663
Scope note: An antineoplastic agent derived from BLEOMYCIN.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antibiotics, Antineoplastic
Registry Number: 56H9L80NIZ
CAS Type 1 Name: Bleomycinamide, N1-(3-((1-phenylethyl)amino)propyl)-, (S)-
Previous Indexing: Bleomycins (1979-1993)
Public MeSH Note: 94; PEPLEOMYCIN was indexed under BLEOMYCINS 1979-93
Online Note: use PEPLOMYCIN (NM) to search PEPLEOMYCIN 1980-93
History Note: 94; was PEPLEOMYCIN (NM) 1979-93
DeCS ID: 31201
Unique ID: D017663
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1994/01/01
Date of Entry: 1993/02/16
Revision Date: 2013/07/08
Peplomycin - Preferred
Concept UI M0026717
Scope note An antineoplastic agent derived from BLEOMYCIN.
Preferred term Peplomycin
Entry term(s) Pepleomycin
NK-631 - Narrower
Concept UI M0357323
Preferred term NK-631
Entry term(s) NK 631
NK631
Peplomycin Sulfate - Narrower
Concept UI M0329228
Preferred term Peplomycin Sulfate
Entry term(s) Peplomycin Sulfate (1:1)
Sulfate, Peplomycin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey